Article citationsMore>>

Guo, X. (2023) A Brief Analysis of the LixiLan-L and Lixilan-L-CN Studies: The Efficacy and Safety of iGlarLixi in the Treatment of Type 2 Diabetes Patients with Poor Basal Insulin Blood Glucose Control. Chinese Journal of Diabetes, 31, 719-720. (In Chinese)

has been cited by the following article:

• TITLE: The Trend of Changes in Insulin Treatment Adherence among Young and Middle-Aged Patients with Type 2 Diabetes Mellitus within Two Months after Discharge: A Longitudinal Observational Study

  AUTHORS: Yijuan Li, Xiaoqing Nong, Shuxian Wang, Qiuhuan Huang, Lianxin Meng, Shuangqi Li

  KEYWORDS: Middle-Aged and Young Adults, Type 2 Diabetes, Insulin Therapy, Treatment Adherence, Influencing Factors

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.14 No.7, July 28, 2026

  ABSTRACT: Objective: The study aimed to investigate the trend of insulin treatment compliance among young and middle-aged patients with type 2 diabetes (T2DM) over time after discharge, providing theoretical basis for clinical practice. Methods: General information questionnaires were collected at the time of discharge. Clinical data were obtained at discharge and two months post-discharge. The Insulin Treatment Adherence Scale was administered at four time points: at discharge, one week post-discharge, one month post-discharge, and two months post-discharge. Results: The overall insulin treatment adherence score and scores across all subscales exhibited a progressive decline over time. Differences in total and subscale scores across time points were statistically significant. Conclusion: Insulin treatment adherence among young and middle-aged T2DM patients progressively declines during the first two months after discharge. Healthcare professionals should implement targeted follow-up protocols and evidence-based interventions for this patient population to improve treatment adherence.